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Caroli’s disease is characterized by an abnormal widening of the intrahepatic biliary ducts. It is also classified as Type V choledochal cysts according to Todani’s 
classification [1,2]. In India, Caroli’s disease attributes to 5% of 
all causes of chronic hepatobiliary diseases [3].
Caroli’s disease Type I (simple type) is most often diagnosed at 
an average age of 20 years. The simple type presents with recurrent 
right upper quadrant pain and recurrent attacks of cholangitis. 
Type II Caroli’s disease is also known as Caroli’s syndrome. It 
is usually associated with autosomal recessive polycystic kidney 
disease (ARPKD) in which the patients may have various degrees 
of renal cysts, interstitial fibrosis, and renal failure and presents 
with features suggestive of portal hypertension [4]. We herein 
report a child who presented at 6 years of age with hematemesis.
CASE REPORT
A 6-year-old boy presented with complaints of 10–12 episodes 
of hematemesis and melena. There was no previous history of 
jaundice, abdominal distension, recurrent fever with the right 
upper quadrant abdominal pain, or similar episodes in the past.
On examination, the child had severe tachycardia (heart rate 
of 182/min), hypotension (blood pressure 80/40 mmHg), feeble 
peripheral pulses, and severe pallor (hemoglobin −3.6 g/dl). There 
were no icterus, cyanosis, clubbing, or significant lymphadenopathy. 
On abdominal examination, the abdomen was distended. The right 
lobe of the liver was palpable 1 cm below the right costal margin, 
and the left lobe was palpable 5 cm below the xiphisternum with a 
smooth surface, sharp leafy margins, and firm consistency. Spleen 
(splenic notch) was palpable 5 cm below the left costal margin in 
midclavicular line with a smooth surface, sharp margins, and firm 
consistency. The liver span was 8 cm on percussion. Kidneys were 
not palpable. No other abdominal masses were palpable. No shifting 
dullness or evidence of free fluid was present on percussion. Other 
systems examination was not remarkable.
On investigations, hemoglobin was 3.6 g/dl, total leukocyte 
count was 3200/mm3, and platelets were 57,000/mm3. Peripheral 
smear for malarial parasite was negative, and red blood cells 
were normocytic and normochromic with leukopenia and 
thrombocytopenia. Investigative work-up for pancytopenia was 
done and the patient was found to have both iron deficiency 
(serum iron - 22 mg/dL and transferrin saturation - 5%) and 
Vitamin B12 (serum B12 levels - 58 ng/mL) deficiency. Liver 
function tests revealed total serum bilirubin as 0.6 mg/dl with 
direct fraction - 0.3 mg/dl and indirect - 0.3 mg/dl, serum 
glutamic-oxaloacetic transaminase - 130 U/dl, serum glutamic 
pyruvic transaminase - 59 U/dl, alkaline phosphatase - 109 IU/L, 
international normalized ratio (INR) - 2.14 and 1.15 after 
administration of Vitamin K and three units fresh frozen plasma, 
and gamma-glutamyltransferase - 21 U/dl. Kidney function tests 
were normal. Viral markers and metabolic workup were negative.
Ultrasonography revealed liver of normal size with coarse 
echotexture and perihepatic free fluid. There was ectasia of intrahepatic 
biliary radicals and gallbladder was contracted with thickened 
irregular walls, moderate splenomegaly, and mild ascites. Upper 
gastrointestinal endoscopy revealed esophageal varices of Grade III 
(Paquet classification) [5] one column and two columns of Grade II, and 
mild antral gastritis. Magnetic resonance cholangiopancreatography 
(MRCP) findings were coarse and shrunken liver with nodular 
surface, distorted architecture with relative caudate, and the left lobe 
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hypertrophy suggestive of changes of chronic liver disease, spleen 
was moderately enlarged in size 18 cm, mild free fluid seen in pelvic 
cavity, multiple portal peripancreatic, pre-paraaortic, aortocaval, 
and retrocaval mesenteric lymphadenopathy with largest measuring 
approximately 20 mm in size (Fig. 1). Bilobar intrahepatic biliary 
radicals are moderately dilated with patent confluence with cystic 
dilatation of the right lobar intrahepatic biliary radical; however, 
common bile duct was not found to be dilated (Fig. 2). Gallbladder 
was found to be contracted with peri-gallbladder and periportal 
fibrosis. Both kidneys were normal.
Liver biopsy findings showed distorted liver architecture 
with the presence of multiple jigsaws shaped nodules separated 
by a marked fibrous expansion of portal tracts with portal tracts 
showing multiple proliferating small irregular bile ducts few of 
which are dilated (ductal plate malformation) along with mild 
focal chronic inflammation with lymphoid aggregate formation. 
On reticulin stain, single-cord pattern is seen with the final 
impression as congenital hepatic fibrosis.
The patient was given supportive care with packed red 
blood cells and fresh frozen plasma transfusion, Vitamin K, and 
other fat-soluble vitamins were given along with proton-pump 
inhibitors and ursodeoxycholic acid. Endoscopic band ligation of 
esophageal varices was done. Patient’s attendants were explained 
about the prognosis and referred for liver transplantation as 
definitive management. Propranolol prophylaxis was started.
DISCUSSION
Caroli’s disease is a rare autosomal recessive congenital disorder 
characterized by non-obstructive, saccular or fusiform, multifocal, 
segmental dilatation of the intrahepatic bile ducts. Sometimes, the 
extrahepatic duct involvement has also been reported. ARPKD 
and Caroli’s syndrome share the same genetic defect, i.e., PHKD1 
mutation on chromosome 6p21 [6,7].
The simple (Type I) Caroli’s disease presents with recurrent 
cholangitis and cholelithiasis while type II presents with 
cirrhosis and portal hypertension. There is an increased risk of 
cholangiocarcinoma in Type II (2.5–17%) and the prognosis is 
poor. The case we have discussed had Type II Caroli’s disease. 
Liver biopsy and MRCP confirmed associated hepatic fibrosis in 
the patient. For localized disease, lobectomy may be considered 
while generalized disease needs liver transplantation. The case we 
discussed had diffuse fibrosis, so the liver transplant was advised. 
In a case series of 104 Caroli’s disease patients, 96 patients 
underwent liver transplantation alone and eight underwent 
combined liver/kidney transplantation.
The patient survival and graft survival were analyzed by 
Kaplan–Meier survival analysis, and the risk of death and graft 
loss were analyzed by Cox proportional hazards regression. The 
overall 1-, 3-, and 5-year graft (79.9%, 72.4%, and 72.4%) and 
patient (86.3%, 78.4%, and 77%) survival rates were excellent 
for patients after liver transplantation. For combined liver/kidney 
transplantation (n = 8), the 1-year patient survival and graft 
survival were 100%. Proportional hazards analysis identified 
Asian ethnicity, elevated bilirubin, requirement of life support or 
hospitalization before transplantation, and a cold ischemia time 
>12 h as associated with increased risk of both graft loss and 
death. A history of prior transplant or prior abdominal surgery 
was also associated with an increased risk of graft loss [8].
Liver transplantation is an excellent treatment option for 
patients with advanced Caroli’s disease and should be considered 
in a timely fashion to prevent worsening complications including 
refractory cholangitis and cholangiocarcinoma.
CONCLUSION
The classical clinical presentation of recurrent abdominal pain and 
jaundice is not always present in patients with Caroli’s syndrome. 
A high index of clinical suspicion is needed for the diagnosis.
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Figure 1: Magnetic resonance cholangiopancreatography - axial 
T2-weighted image showing caudate lobe hypertrophy and 
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Figure 2: Magnetic resonance cholangiopancreatography - axial 
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